Details

Autor(en) / Beteiligte

• De Smedt, Delphine
• Clays, Els
• Höfer, Stefan
• Oldridge, Neil
• Kotseva, Kornelia
• Maggioni, Aldo Pietro
• Pogosova, Nana
• Dolzhenko, Maryna
• De Bacquer, Dirk

Titel

The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology

Ist Teil von

• European journal of preventive cardiology, 2016-07, Vol.23 (11), p.1174-1186

Ort / Verlag

London, England: SAGE Publications

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Background HeartQoL is a recently developed core health-related quality of life instrument for patients with coronary heart disease. The current study aims to investigate its association with patients’ coronary risk profile and to provide reference values for patients with coronary heart disease across Europe. Design Analyses are based on the EUROASPIRE IV (EUROpean Action on Secondary and Primary prevention through Intervention to Reduce Events) cross-sectional survey. Methods Patients with a diagnosis of coronary heart disease were examined and interviewed six months to three years after their coronary event. The HeartQoL questionnaire was completed by 7261 coronary heart disease patients. Reference values were calculated and the association with the coronary risk profile was assessed. Results Significantly worse outcomes were observed in higher-risk patient groups. Both metabolic and behavioural risk factors were associated with worse HeartQoL outcomes. Further, the HeartQoL scores decreased as the number of risk factors increased. The mean global reference values in males were 2.27 ± 0.65 (<60 years), 2.30 ± 0.61 (between 60 and 69 years) and 2.19 ± 0.64 (≥70 years). Likewise, in females, the respective global HeartQoL reference values were 2.02 ± 0.67, 2.01 ± 0.66 and 1.83 ± 0.70. The ceiling effect in males was 11.4%, 10.4% and 7.4% for the three age classes respectively, whereas in females the ceiling effect was 5.2%, 3.5% and 1.9%, respectively. Conclusion HeartQoL scores were associated with patients’ coronary risk profile. The reference values may help other researchers to interpret HeartQoL scores. Further research should focus on the minimal important difference needed to evaluate the effect of therapies and lifestyle changes.